title: Multiple myeloma. Analysis of fifty cases.
abstract: Fifty patients of multiple myeloma have been studied. Seventy eight per cent of the patients were in the 5th, 6th and 7th decades of life. Commonest presenting feature was bone pains (76%). 8%, 20% belonged to stage I, II and III respectively. Skull (58%), ribs (52%) and pelvis (24%) were most commonly involved. Immunoelectrophoresis revealed IgG type of myeloma in 76% and IgA type in 10% cases. Bence-Jones proteinuria was seen in 60% of patients; Kappa specificity was commoner than lambda. Overall survival at 30 months was 50%. The survival was adversely influenced by advanced stage, higher plasma cell count in the bone marrow, low haemoglobin and high serum creatinine values.
authors.forename: P
authors.initials: P
authors.lastname: Venugopal
authors.forename: A
authors.initials: A
authors.lastname: Rajni
authors.forename: R
authors.initials: R
authors.lastname: Gopal
authors.forename: C N
authors.initials: CN
authors.lastname: Nair
authors.forename: P A
authors.initials: PA
authors.lastname: Kurkure
authors.forename: T K
authors.initials: TK
authors.lastname: Saikia
authors.forename: K S
authors.initials: KS
authors.lastname: Nadkarni
authors.forename: S K
authors.initials: SK
authors.lastname: Pai
authors.forename: V R
authors.initials: VR
authors.lastname: Pai
authors.forename: S H
authors.initials: SH
authors.lastname: Advani
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000532:radiotherapy; D011879:Radiotherapy Dosage